GlassScriptPhysician profile
Stephanie Oexeman
NPI 1427419373
$206,477.87
in general payments reported to CMS, 2019-2025
25 companies · $18K in 2025
The $18K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $203 · 2021: $16K · 2022: $57K · 2023: $54K · 2024: $61K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $87K · Travel and Lodging: $41K · Food and Beverage: $5,493 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $86,717.90 |
| Travel and Lodging | $40,609.74 |
| Food and Beverage | $5,493.08 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $106,715.69 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Orthofix Medical, INC. | $88,522.36 | 2021-2024 | Truelok, Truelok System, Physio-Stim |
| Medwest Associates | $3,074.18 | 2021-2023 | |
| Arthrex, INC. | $2,507.81 | 2022-2025 | |
| Stryker Corporation | $1,194.90 | 2021-2024 | Augment Injectable, Allograft Bio-Implants, Infinity Adaptis |
| Fff Enterprises, INC. | $1,000.00 | 2024 | |
| Lightbody Medical Technologies INC | $541.82 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $402.30 | 2021 | |
| Axogen | $368.90 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Smith+Nephew, INC. | $345.48 | 2022-2025 | Grafix Pl |
| Sanara Medtech INC. | $293.26 | 2021 | |
| Checkpoint Surgical, INC | $223.03 | 2021-2022 | |
| Arteriocyte Medical Systems, INC. | $203.34 | 2020 | |
| Acera Surgical, INC. | $166.62 | 2021-2022 | |
| Kerecis Limited | $150.52 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $145.01 | 2022 | |
| Bone Support INC. | $126.60 | 2022 | |
| Melinta Therapeutics, LLC | $116.98 | 2022 | |
| Horizon Therapeutics Plc | $110.71 | 2021 | |
| Baudax Bio INC. | $92.23 | 2021 | |
| Bioventus LLC | $72.57 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Paragon 28, INC. | $53.24 | 2024-2025 | Precision Mis Bunion, Mtp |
| Depuy Synthes Sales INC. | $18.19 | 2022 | |
| Treace Medical Concepts, INC. | $17.34 | 2024 | |
| Medline Industries LP | $14.79 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Oexeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.